Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

BACKGROUND: Thrombotic disorders remain one of the leading causes of death in the Western world. Dabigatran appeared as an alternative to warfarin for anticoagulation in the treatment of atrial fibrillation (AF). The risk associated with bleeding due to its use has been documented in several randomi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Arq Bras Cardiol
Auteurs principaux: Andrade, Marcus Vinicius Santos, Andrade, Luciana Azevedo Prata, Bispo, Alan Freitas, Freitas, Luana de Alencar, Andrade, Milena Quadros Sampaio, Feitosa, Gilson Soares, Feitosa-Filho, Gilson Soares
Format: Artigo
Langue:Inglês
Publié: Sociedade Brasileira de Cardiologia - SBC 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173350/
https://ncbi.nlm.nih.gov/pubmed/30088558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/abc.20180137
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires